- Home
- WYHG vs DRTS Comparison
WYHG vs DRTS Comparison
Compare WYHG & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYHG
- DRTS
- Stock Information
- Founded
- WYHG 1915
- DRTS 2015
- Country
- WYHG China
- DRTS Israel
- Employees
- WYHG 491
- DRTS N/A
- Industry
- WYHG
- DRTS Medical/Dental Instruments
- Sector
- WYHG
- DRTS Health Care
- Exchange
- WYHG NYSE
- DRTS Nasdaq
- Market Cap
- WYHG 261.7M
- DRTS 259.4M
- IPO Year
- WYHG 2024
- DRTS N/A
- Fundamental
- Price
- WYHG $10.06
- DRTS $2.70
- Analyst Decision
- WYHG
- DRTS Strong Buy
- Analyst Count
- WYHG 0
- DRTS 2
- Target Price
- WYHG N/A
- DRTS $8.00
- AVG Volume (30 Days)
- WYHG 353.7K
- DRTS 108.6K
- Earning Date
- WYHG 01-01-0001
- DRTS 03-06-2025
- Dividend Yield
- WYHG N/A
- DRTS N/A
- EPS Growth
- WYHG 10.09
- DRTS N/A
- EPS
- WYHG 0.27
- DRTS N/A
- Revenue
- WYHG $144,231,605.00
- DRTS N/A
- Revenue This Year
- WYHG N/A
- DRTS N/A
- Revenue Next Year
- WYHG N/A
- DRTS N/A
- P/E Ratio
- WYHG $5.05
- DRTS N/A
- Revenue Growth
- WYHG 9.73
- DRTS N/A
- 52 Week Low
- WYHG $3.55
- DRTS $1.75
- 52 Week High
- WYHG $5.35
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- WYHG N/A
- DRTS 28.95
- Support Level
- WYHG N/A
- DRTS $2.95
- Resistance Level
- WYHG N/A
- DRTS $3.19
- Average True Range (ATR)
- WYHG 0.00
- DRTS 0.21
- MACD
- WYHG 0.00
- DRTS -0.08
- Stochastic Oscillator
- WYHG 0.00
- DRTS 3.85
About WYHG WING YIP FOOD HOLDINGS GROUP LTD SPON ADS EACH REP 1 ORD
Wing Yip Food Holdings Group Ltd is a meat producer. The company is mainly engaged in offering ready to eat and packaged meat dishes. Its product offerings include supreme crispy sausage, fully thin sausage, Chinese sausage, Dongguan Erba sausage, yellow scorpion sausage, alcohol sausage, and meat chop.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.